Related Experiment Video
Updated: Jan 10, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Peritoneal Cancer Index Dominates Prognosis After CRS-HIPEC for Colorectal Peritoneal Metastases: A Consecutive
Michał Kazanowski1, Paweł Lesiak1, Jędrzej Wierzbicki1,2
1Department of Surgical Oncology, Pulmonology and Hematology, Lower Silesian Center of Oncology, 53-413 Wroclaw, Poland.
Background:
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) can cure selected patients with colorectal peritoneal metastases (CPM). Real-world prognostic data, especially for the Peritoneal Cancer Index (PCI) and completeness of cytoreduction (CCR), are limited.
Methods:
We retrospectively analysed 75 consecutive patients treated with CRS + HIPEC at a tertiary centre (2014-2022), giving ≥36 months potential follow-up. Overall survival (OS) was assessed by Kaplan-Meier and Cox models. PCI was grouped 0-10, 11-20, >20; CCR was dichotomised (CCR-0 vs. CCR 1/2). Multivariable analysis included PCI, CCR, and resection extent; HIPEC drug was examined univariately.
Results:
The median follow-up was 41 months. Crude 3-year OS was 50.7% (38/75). Survival decreased with higher PCI: 69% for 0-10 (n = 42), 38% for 11-20 (n = 21), and 0% for > 20 (n = 4). Versus PCI 0-10, the adjusted hazard ratios (HR) were 3.02 (95% CI 1.52-6.03) for PCI 11-20 and 7.29 (1.72-30.81) for > 20. CCR-0 improved OS univariately (HR 0.43) but was non-significant after adjustment (HR 0.89). Resection limited to the peritoneum (HR 0.99) and choice of intraperitoneal drug showed no independent effect.
Conclusions:
In this real-world cohort, PCI was the only independent predictor of 3-year survival after CRS + HIPEC for CPM; neither CCR status, surgical extent, nor HIPEC agent altered prognosis once PCI was considered. PCI should therefore remain the principal selection criterion while molecular and biological markers are integrated into future risk models.
More Related Videos
04:50Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
